Literature DB >> 21378261

Epithelial interactions and local engraftment of lung-resident mesenchymal stem cells.

Linda Badri1, Natalie M Walker, Takashi Ohtsuka, Zhuo Wang, Mario Delmar, Andrew Flint, Marc Peters-Golden, Galen B Toews, David J Pinsky, Paul H Krebsbach, Vibha N Lama.   

Abstract

Multipotent mesenchymal progenitor cells, termed "mesenchymal stem cells" (MSCs), have been demonstrated to reside in human adult lungs. However, there is little information regarding the associations of these local mesenchymal progenitors with other resident somatic cells and their potential for therapeutic use. Here we provide in vivo and in vitro evidence for the ability of human adult lung-resident MSCs (LR-MSCs) to interact with the local epithelial cells. The in vivo retention and localization of human LR-MSCs in an alveolar microenvironment was investigated by placing PKH-26 or DsRed lentivirus-labeled human LR-MSCs in the lungs of immunodeficient (SCID) mice. At 3 weeks after intratracheal administration, 19.3 ± 3.21% of LR-MSCs were recovered, compared with 3.47 ± 0.51% of control fibroblasts, as determined by flow cytometry. LR-MSCs were found to persist in murine lungs for up to 6 months and demonstrated preferential localization to the corners of the alveoli in close proximity to type II alveolar epithelial cells, the progenitor cells of the alveolar epithelium. In vitro, LR-MSCs established gap junction communications with lung alveolar and bronchial epithelial cells and demonstrated an ability to secrete keratinocyte growth factor, an important modulator of epithelial cell proliferation and differentiation. Gap junction communications were also demonstrable between LR-MSCs and resident murine cells in vivo. This study demonstrates, for the first time, an ability of tissue-specific MSCs to engraft in their organ of origin and establishes a pathway of bidirectional interaction between these mesenchymal progenitors and adult somatic epithelial cells in the lung.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21378261      PMCID: PMC3208618          DOI: 10.1165/rcmb.2010-0446OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  42 in total

1.  Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice.

Authors:  Naveen Gupta; Xiao Su; Boris Popov; Jae Woo Lee; Vladimir Serikov; Michael A Matthay
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

2.  Cell tracking 2007: a proliferation of probes and applications.

Authors:  Paul K Wallace; Katharine A Muirhead
Journal:  Immunol Invest       Date:  2007       Impact factor: 3.657

Review 3.  Transcriptional control of lung morphogenesis.

Authors:  Yutaka Maeda; Vrushank Davé; Jeffrey A Whitsett
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 4.  Human bone marrow mesenchymal stem cells in vivo.

Authors:  E Jones; D McGonagle
Journal:  Rheumatology (Oxford)       Date:  2007-11-06       Impact factor: 7.580

Review 5.  Cross-talk between pulmonary injury, oxidant stress, and gap junctional communication.

Authors:  Latoya N Johnson; Michael Koval
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

6.  Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.

Authors:  Krisztián Németh; Asada Leelahavanichkul; Peter S T Yuen; Balázs Mayer; Alissa Parmelee; Kent Doi; Pamela G Robey; Kantima Leelahavanichkul; Beverly H Koller; Jared M Brown; Xuzhen Hu; Ivett Jelinek; Robert A Star; Eva Mezey
Journal:  Nat Med       Date:  2008-11-21       Impact factor: 53.440

7.  Novel markers for the prospective isolation of human MSC.

Authors:  Hans-Jörg Bühring; Venkata Lokesh Battula; Sabrina Treml; Bernhard Schewe; Lothar Kanz; Wichard Vogel
Journal:  Ann N Y Acad Sci       Date:  2007-03-29       Impact factor: 5.691

8.  Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells.

Authors:  Keishi Otsu; Shonit Das; Sandra D Houser; Sadiqa K Quadri; Sunita Bhattacharya; Jahar Bhattacharya
Journal:  Blood       Date:  2008-11-25       Impact factor: 22.113

9.  Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart.

Authors:  M J Hoogduijn; M J Crop; A M A Peeters; S S Korevaar; M Eijken; J J Drabbels; D L Roelen; A P M M Maat; A H M M Balk; W Weimar; C C Baan
Journal:  Am J Transplant       Date:  2008-10-31       Impact factor: 8.086

10.  Altered intercellular communication in lung fibroblast cultures from patients with idiopathic pulmonary fibrosis.

Authors:  Angela Trovato-Salinaro; Elisa Trovato-Salinaro; Marco Failla; Claudio Mastruzzo; Valerio Tomaselli; Elisa Gili; Nunzio Crimi; Daniele Filippo Condorelli; Carlo Vancheri
Journal:  Respir Res       Date:  2006-09-27
View more
  34 in total

1.  Effects of Agricultural Organic Dusts on Human Lung-Resident Mesenchymal Stem (Stromal) Cell Function.

Authors:  Tara M Nordgren; Kristina L Bailey; Art J Heires; Dawn Katafiasz; Debra J Romberger
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

Review 2.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

3.  An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.

Authors:  Daniel J Weiss; Daniel Chambers; Adam Giangreco; Armand Keating; Darrell Kotton; Peter I Lelkes; Darcy E Wagner; Darwin J Prockop
Journal:  Ann Am Thorac Soc       Date:  2015-04

Review 4.  The lung communication network.

Authors:  Davide Losa; Marc Chanson
Journal:  Cell Mol Life Sci       Date:  2015-06-23       Impact factor: 9.261

5.  Prostaglandin E2 as an inhibitory modulator of fibrogenesis in human lung allografts.

Authors:  Natalie M Walker; Linda N Badri; Anish Wadhwa; Scott Wettlaufer; Marc Peters-Golden; Vibha N Lama
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

6.  Therapeutic potential of porcine bronchoalveolar fluid-derived mesenchymal stromal cells in a pig model of LPS-induced ALI.

Authors:  Mahesh Khatri; Levi A Richardson
Journal:  J Cell Physiol       Date:  2018-01-19       Impact factor: 6.384

Review 7.  Lung-resident mesenchymal stromal cells are tissue-specific regulators of lung homeostasis.

Authors:  Stefanie Noel Sveiven; Tara M Nordgren
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-13       Impact factor: 5.464

8.  Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis.

Authors:  Pengxiu Cao; Yoshiro Aoki; Linda Badri; Natalie M Walker; Casey M Manning; Amir Lagstein; Eric R Fearon; Vibha N Lama
Journal:  J Clin Invest       Date:  2017-02-27       Impact factor: 14.808

9.  Therapeutic potential of mesenchymal stem cell transplantation in a nitrofen-induced congenital diaphragmatic hernia rat model.

Authors:  Ratih Yuniartha; Fatima Safira Alatas; Kouji Nagata; Masaaki Kuda; Yusuke Yanagi; Genshiro Esumi; Takayoshi Yamaza; Yoshiaki Kinoshita; Tomoaki Taguchi
Journal:  Pediatr Surg Int       Date:  2014-08-05       Impact factor: 1.827

10.  New approach of bone marrow-derived mesenchymal stem cells and human amniotic epithelial cells applications in accelerating wound healing of irradiated albino rats.

Authors:  Samah S Mehanni; Noha F Ibrahim; Alyaa R Hassan; Laila A Rashed
Journal:  Int J Stem Cells       Date:  2013-05       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.